Catalyst Pharmaceuticals Inc (CPRX)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Operating income (ttm)	US$ in thousands	86,812	75,921	138,211	120,081	101,838	83,779	72,681	59,950	52,385	48,261	45,961	40,405	41,304	40,693	42,834	43,511	31,823	8,973	-13,055	-30,350
Total assets	US$ in thousands	470,114	413,211	443,896	407,227	375,630	333,114	267,309	246,972	237,788	223,248	209,130	197,216	192,354	174,860	131,412	117,880	112,376	96,691	78,234	61,077
Operating ROA		18.47%	18.37%	31.14%	29.49%	27.11%	25.15%	27.19%	24.27%	22.03%	21.62%	21.98%	20.49%	21.47%	23.27%	32.60%	36.91%	28.32%	9.28%	-16.69%	-49.69%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $86,812K ÷ $470,114K
= 18.47%

The operating return on assets (ROA) of Catalyst Pharmaceuticals Inc has shown a fluctuating trend over the time period indicated. The ROA ranged from a low of -49.69% in March 2019 to a high of 36.91% in March 2020, with some significant variations in between.

The company's performance in generating operating profits relative to its assets improved steadily from negative levels in 2019 to positive figures in subsequent years, reaching a peak in March 2020. However, the ROA experienced a decline in the most recent financial period, standing at 18.47% in December 2023.

These variations in operating ROA could be influenced by changes in the company's operating efficiency, asset utilization, cost management, revenue generation, or other operational factors. It is essential for stakeholders to further analyze the company's financial statements and operational performance to gain a deeper understanding of the drivers behind these changes in operating ROA.